Volume 201 - Issue 8

Survival, mortality and morbidity outcomes after oesophagogastric cancer surgery in New South Wales, 2001–2008

Authors:  Nicola Creighton, Ross C Smith and David C Currow

Med J Aust 2014; 201 (8): 447. || doi: 10.5694/mja14.00975
Published online: 20 October 2014
In reply: Does institutional volume matter?

In reply: International evidence of high-volume institutions having better outcomes for complex cancer surgery is strong.1,2 Our analyses confirm the direction and magnitude of this relationship in New South Wales. Should we ignore the international evidence?

Our analyses showed improved 5-year survival for people with oesophagogastric cancer who received surgery in a higher-volume hospital. The difference in survival was not explained by the age, comorbidity, extent of disease or urgency of admission. We used hospital volume as a measure of hospital experience in the surgical and non-surgical management of oesophagogastric cancer patients. More accurate staging and more effective delivery of adjuvant therapy may be part of the reason for the volume–outcome relationships observed. Patient outcomes are determined by more than what happens on the operating table. This is not about the surgeon but about performing complex procedures frequently enough in institutions able to provide the range of diagnostics, perioperative support services, multidisciplinary care and expertise that surgeons require and patients need for great outcomes.3,4 Can anyone defend institutions performing these procedures at a low volume?


Authors


Competing interests


References


More like this

Cancer Research 18 August 2026 Open Access

Uneven Ground: Survival Differences Among Victorian Lung Cancer Patients by Location of Residence (2011–2023): A Retrospective Cohort Study

Evangeline Samuel, Eldho Paul, Mike Lloyd, Sanuki Tissera, Craig Underhill, Sagun Parakh, Phillip Parente, Inger Olesen, Javier Torres, Katharine See, Gavin M. Wright, David Langton, Thomas John, Matthew Conron, James Bartlett, Nicola Atkin, Nikolajs Zeps, Susan V. Harden, Wasek Faisal, John R. Zalcberg, Rob G. Stirling

Cancer Research 18 August 2026 Open Access

Early-Onset Colorectal Cancer With Liver-Only Metastases: A Retrospective Cohort Study Integrating Prospectively Collected Real-World Clinical and Molecular Data From an Australian National Database (2009–2024) to Guide Treatment Planning

Savio G. Barreto, Christos S. Karapetis, Shahid Ullah, Matthew Burge, Susan Caird, Angus Campbell, Azim Jalali, Ross Jennens, Muhammad A. Khattak, Belinda Lee, Stephanie H. Lim, Shehara Mendis, Louise Nott, Timothy J. Price, Jeremy D. Shapiro, Jeanne Tie, Javier Torres, Colin Williams, Rachel Wong, Vanessa Wong, Peter Gibbs

Cancer Guideline summary 13 July 2026 Open Access

Program Guidelines for the National Lung Cancer Screening Program: Targeted Lung Cancer Screening in High-Risk Individuals in Australia

Nicole M. Rankin, Rebecca Zosel, Lisa J. Whop, Raglan Maddox, Annette McWilliams, Miranda Siemienowicz, Jon Emery, Maria A. R. Lantin, Georgia Bartlett, Mikayla Wolfe, Abbey Diaz, Katrina Anderson, Lillian Liu, Cindy Toms, Sarah McDermott, Peter Bligh, Jeremy Chalke, Stephen Melsom, Claire E. Nightingale, Alison Brown, Sam Pope, Julia Brotherton, Anne Fidler, Michel Itel, Mark Brooke, Diane M. Pascoe, Fraser Brims, Tracy L. Leong, Emily Stone, Dorothy Keefe, Vivienne Milch